End Cervical Cancer

Honoring the Legacy of Professor Lynette Denny

It is with profound sadness and a deep sense of loss that we, the community of Cervivor, Inc., join in mourning the passing of Professor Lynette Denny.

A devoted individual in the mission to end cervical cancer, Professor Denny’s contributions to women’s health, particularly in low-resource settings, have left a lasting mark on the world.

As the Chair and Professor of Obstetrics & Gynaecology and a registered sub-specialist in gynecological oncology at Groote Schuur Hospital and the University of Cape Town, Professor Denny dedicated her life to improving the quality of life for women globally. Her passion for preventing cervical cancer was evident in her extensive research over the past 15 years, culminating in over 100 peer-reviewed papers. Her insights and findings have guided countless healthcare professionals and researchers in their quest to eradicate this preventable disease.

Professor Denny was a wealth of knowledge and inspiration, gracing numerous international conferences as a keynote speaker. Her expertise and commitment were recognized by many prestigious awards, including the “Distinguished Scientist for Improving the Quality of Life of Women” by the South African Department of Science and Technology in 2006, the Shoprite Checkers SABC 2 “Women of the Year” award for Science and Technology in 2004, and the South African Medical Association award for “Extraordinary Service to Medicine” in 2012. Her accolades also include a Fellowship ad eudeum by the Royal College of Obstetrics and Gynaecology in the United Kingdom and the British Society of Colposcopy and Cervical Pathology Founders’ Medal in 2014.

In March 2015, Professor Denny’s outstanding work was further recognized with the SA Medical Research Council award for a Cancer Research Centre project, reflecting her leadership in the SAMRC/UCT Gynaecological Cancer Research Centre. Her efforts were also acknowledged by the CANSA AG Oettle Memorial Award and the International Federation of Gynaecology and Obstetrics (FIGO) Award in 2015, as well as the International Agency for Research on Cancer (IARC) Medal of Honour Award in 2016.

As the immediate Past President of IGCS and immediate Past Chair of the FIGO Gynaecologic Cancer Committee, Professor Denny’s influence extended far and wide. Her collaborative spirit and ability to secure substantial funding for innovative research have paved the way for future breakthroughs in cancer prevention and treatment.

Professor Denny’s legacy is not only etched in her scientific achievements but also in the countless lives she touched and improved through her work. Her dedication, compassion, and tireless efforts have created a brighter future for women worldwide, particularly those in disadvantaged communities.

In remembering Professor Lynette Denny, we honor a true pioneer, a dedicated researcher, and a compassionate advocate for women’s health. Her legacy will continue to inspire and guide us in our mission to prevent cervical cancer and support those affected by it. We extend our deepest condolences to her family, friends, colleagues, and all who were fortunate to know and work with her.

Rest in peace, Professor Denny. Your light will continue to shine brightly in our hearts and in the ongoing mission to end cervical cancer.

Honors in Advocacy for our Leaders in the Mission to End Cervical Cancer

In the relentless mission to end cervical cancer, every victory, every recognition, is a puzzle piece of hope, a testament to the dedication of those who tirelessly advocate for progress. Today, we are honored and humbled to celebrate the remarkable achievements of three extraordinary individuals who have devoted their lives to championing the cause of cancer patients, survivors, and advocates.

Tamika Felder, Founder & Chief Visionary

At the forefront of our celebration is Tamika Felder, our Founder and Chief Visionary, whose journey from patient to nonprofit founder has been nothing short of inspiring. In 2001, Tamika faced a daunting diagnosis of cervical cancer, a moment that would change her life forever. Determined to turn her personal struggle into a source of strength for others, Tamika founded Cervivor in 2005, an organization dedicated to educating and empowering cervical cancer patients and survivors to share their stories and make a difference.

For the past 19 years, Tamika has been a trailblazer in the mission to end cervical cancer, always advocating for the voices of patients and survivors to be heard. Her commitment and relentless efforts have earned her the incredible honor of being appointed to the National Cancer Advisory Board by President Joe Biden. This appointment is not only a testament to Tamika’s extraordinary leadership but also a recognition of the vital role that she and Cervivor play in shaping the future of cancer research, treatment, and prevention.

The National Cancer Advisory Board plays a crucial role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research program. As we work towards President Biden’s ambitious goal of ending cancer as we know it through initiatives like the Cancer Moonshot, Tamika’s appointment ensures that the voices of cervical cancer patients and survivors will be heard loud and clear at the highest levels of decision-making.

Morgan Newman, MSW, Community Engagement Liaison

We are also thrilled to celebrate the achievements of Morgan Newman, our Community Engagement Liaison, who has been selected as a patient advocate member for the National Cancer Institute (NCI) Gynecologic Cancer Steering Committee (GCSC) Cervical Task Force (CTF). Morgan’s dedication to ensuring that patient voices are integrated into the development and evaluation of clinical trials is truly commendable. Through her involvement in these committees, Morgan is helping to shape the future of gynecologic cancer research and treatment, ensuring that the needs and perspectives of patients are always front and center.

Kimberly Williams, MHCM, Chief Diversity Equity & Inclusion Officer

Last but certainly not least, we extend our heartfelt congratulations to Kimberly Williams, our Chief Diversity Equity and Inclusion Officer, for her continuous role as a patient advocate member for the Cervix/Vulva Cancer Committee for NRG Oncology. Kimberly’s tireless advocacy efforts have been instrumental in improving the clinical research process and ensuring that patient perspectives are always prioritized. Her recent appointment to the Diversity, Equity, and Inclusion Committee further underscores her commitment to advancing equity and inclusion in cancer research and treatment for all.

As we celebrate these remarkable achievements, we are reminded of the power of advocacy and the incredible impact that individuals like Tamika, Morgan, and Kimberly can have in the mission to end cervical cancer. Their dedication, passion, and advocacy serve as an inspiration to us all, and we are proud to stand alongside them in the quest for a world free from cervical cancer.

To learn more about Tamika Felder’s appointment to the National Cancer Advisory Board, please see the official press release from the White House [here].